Minimum lethal concentrations (MLC) and minimum inhibitory concentrations (MIC) were determined in vitro for 8 antibiotics against 9 isolates of Mycoplasma synoviae. Of the antibiotics tested, tylosin had the highest activity, followed closely by chlortetracycline, lincomycin, oxytetracycline, spectinomycin, and tetracycline. Neomycin and erythromycin were less effective. Two antibiotic combinations (lincomycin-spectinomycin and oxytetracyclineneomycin) had greater mycoplasmacidal activity than either member of the combination acting alone.
INTRODUCTION

Mycoplasma synoviae is the etiologic agent of infectious synovitis of chickens. The organism was first described by Chalquest and Fabricant (1) and was named Mycoplasma synoviae by Olson et al. (8). M. synoviae was designated serotype S by Dierks et al. (2). This organism is capable of producing air-sac lesions in young chickens and may also play an important role in airsacculitis condemnations in broilers (5,9).
Although considerable data have been obtained on the in vitro antibiotic susceptibility of M. gallisepticum and other avian mycoplasmas (4,6), no information is available on the in vitro susceptibility of M. synoviae. Tetracyclines have been shown to be effective in vivo in the treatment of experimental infectious synovitis (7). This communication reports on the in vitro susceptibility of 9 strains of M. synoviae to 8 commonly used antibiotics. When growth occurred in the control tube, a definite change was observed of the phenol red to yellow (usually after 24 hr of incubation), and the minimum inhibitory concentration (MIC) was determined. The MIC was the lowest concentration of antibiotic inhibiting growth (no color change of phenol red). When the MIC was determined, approximately 0.01 ml of broth from each tube was placed on an agar plate. The plates were incubated at 37 C in a moist container and examined microscopically after 5 days for mycoplasma colonies. The minimum lethal concentration (MLC) was the lowest antibiotic concentration which yielded no mycoplasma colonies on agar.
To determine the effect of certain antibiotic combinations (lincomycin-spectinomycin and oxytetracycline-neomycin), the MIC and MLC were determined for each antibiotic alone and for the combination. Ratios of 1 part lincomycin to 2 parts spectinomycin (4) and 1 part oxytetracycline to 0.7 part neomycin (Neo Terramycin Soluble Powder Concentrate) were used. Table 1 gives the MIC and MLC for each antibiotic for 9 isolates of M. synoviae at the initial screening levels of 40, 20, and 10 /g/ml. All antibiotics except erythromycin showed activity at 10 /Fg/ml for at least 1 isolate. Therefore, all antibiotics except erythromycin were included in the next trial. Table 2 gives the MIC and MLC of each isolate at levels of 8 ,ug/ml and below for each antibiotic used. Several individual determinations were repeated, and the results were always in good agreement.
RESULTS
Tylosin showed the best in vitro activity, giving MIC's of 0.063 ,Lg/ml, and MLC's for most isolates at 0.125 ,g/ml. One isolate, however, had an MLC of 8 ,g/ml with tylosin. Chlortetracycline, oxytetracycline, and tetracycline had MIC's ranging from 0.125 to 2 Lg/ml, with oxytetracycline being most effective. These 3 antibiotics had MLC's ranging from 10 to 40 /Ag/ml. Spectinomycin gave MIC's of 0.5 to 2 ,g/ml and MLC's ranging from 2 to 10 Ag/ml, while lincomycin showed MIC's of 1-2 Ag/ml and MLC's from 4 to 20 /,g/ml. Neomycin had MIC's from 2 to 40 ,g/ml and MLC's from 10 to 40 ,ug/ml, and erythromycin was relatively ineffective under the conditions of this trial. Table 3 gives MIC's and MLC's of lincomycin and spectinomycin, singly and in combination, against 4 isolates of M. synoviae. The combination appeared to have a synergistic effect, especially on mycoplasmacidal activity against relatively insensitive isolates. The MIC's and MLC's of oxytetracycline and neomycin are given in Table 4 . The MLC of the combination appears to be considerably lower than that of either antibiotic alone against 1 isolate (51 AS), 
DISCUSSION
Although it is well accepted that in vitro antibiotic sensitivities may vary with changes in experimental conditions, MIC's obtained for oxytetracycline, tetracycline, chlortetracycline, lincomycin, spectinomycin, and tylosin against isolates of M. synoviae are comparable to results obtained by other workers (4,6) with other avian mycoplasmas. In contrast to favorable in vitro results using erythromycin against M. gallisepticum (6), erythromycin was relatively ineffective against M. synoviae.
Tylosin appeared to be the most effective of the antibiotics tested, with MIC's of 0.063 ug/ml. The MLC was only slightly higher, indicating that this antibiotic has mycoplasmacidal activity at concentrations only slightly above the MIC. One isolate (1331) had an MLC with tylosin considerably higher than those of the other isolates, even though its MIC was the same. This is an isolate that has been a standard laboratory strain of M. synoviae for some time, and it may have been exposed to tylosin at some point in its history.
Very favorable MIC's were also obtained with chlortetracycline, oxytetracycline, and tetracycline. MLC's were considerably higher than MIC's, indicating mycoplasma-static rather than mycoplasmacidal activity. These results are in agreement with the in vivo effectiveness of tetracyclines in the treatment of experimental infections synovitis (7).
Lincomycin and spectinomycin also gave favorable MIC's and appeared to have somewhat better mycoplasmacidal activity than the tetracycline group.
MIC's with spectinomycin-lincomycin and oxytetracyclineneomycin combinations indicated very little if any synergistic action. However, MLC's of the combinations suggested that greater mycoplasmacidal activity was obtained with both combinations, especially when tested against relatively insensitive isolates.
Even though an antibiotic has high in vitro activity, it is not necessarily active in vivo. Nevertheless, it is hoped that these data may be useful in the search for effective antibiotic treatment of clinical Mycoplasma synoviae infections.
